HSKA @ 1.100 +0.100 10.00% 494K
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
Heska Corporation engages in the discovery, development, manufacture, marketing, sale, and distribution of veterinary products. The company operates in two segments, Core Companion Animal Health (CCA); and Other Vaccines, Pharmaceuticals, and Products (OVP). The CCA segment offers diagnostic and monitoring instruments and supplies; single use diagnostic and other tests; vaccines; and pharmaceuticals, primarily for canine and feline use. This segment primarily provides various products, including handheld electrolyte instrument, chemistry instrument, and hematology instrument and their consumables. The OVP segment offers private label vaccine and pharmaceuticals, primarily for cattle, as well as for other animals, including small mammals, horses, and fish.
financial highlights for the third quarter of 2005 (and as compared to the prior year period -- the third quarter of 2004) were:
- Total revenue of $19.3 million, a 21% increase versus prior year period
- Gross margin of 39.7%, an increase of over 2 percentage points versus prior year period
- $6.2 million in operating expenses - a decrease of over $500 thousand from prior year period
- $1.5 million in income from operations, an improvement of over $2.1 million from prior year period |
